Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Anti-Inflammatory Agents, Non-Steroidal and Arachidonic Acid

Research Papers that Mention the Interaction

The NSAIDs , including aspirin, are relatively specific inhibitors of one branch of the arachidonic acid cascade ; this inhibition occurs through cyclooxygenase inhibition, which may modulate carcinogenesis.
Annals of Internal Medicine  •  1998  |  View Paper
NSAIDs act through inhibition of cyclooxygenase (COX) conversion of arachidonic acid into prostaglandins.
Environmental Science and Pollution Research  •  2017  |  View Paper
For instance, nonsteroidal anti‐inflammatory agents (NSAIDs), both classical nonselective (cNSAIDs) and the selective COX‐2 inhibitors (coxibs) attenuate the generation of PGH2 from AA that in turn reduces the synthesis of PGE2 and modifies the inflammatory conditions.
Medicinal research reviews  •  2014  |  View Paper
Non‐steroidal anti‐inflammatory drugs exert their anti‐inflammatory and antipyretic effects by blocking the production of prostanoids from arachidonic acid through inhibition ofcyclooxygenase enzyme.
Chemical biology & drug design  •  2014  |  View Paper
Nonsteroidal antiinflammatory drugs (NSAIDs) modulating arachidonic acid (AA) metabolism have been utilized in cancer chemoprevention.
Current pharmaceutical design  •  2010  |  View Paper
Since it was initially discovered that non-steroidal anti-inflammatory drugs inhibit prostaglandin synthesis, a vast amount of drug development has been performed to selectively inhibit the production of the inflammatory metabolites of arachidonic acid while preserving their protective role.
Current pharmaceutical design  •  2005  |  View Paper
Administration of nonsteroid anti-inflammatory drugs AID ) inhibits hypotension and bronchoconstriction induced by the polyunsaturated prostaglandin (PG) precursor arachidonic acid (AA) and by slow reacting substance C (SRS-C, a mixture of unsaturated fatty acids split from lecithin by snake venom phospholipase A2).
Furthermore, formation of mediators in PRP by AA was accompanied by a calcium dependent and serum independent platelet aggregation, liable as well to blockade by AID.
Agents and Actions  •  2005  |  View Paper
SummaryAll acidic non-steroidal anti-inflammatory drugs suppress the activity of microsomal cyclo-oxygenase of arachidonic acid ; therefore, these drugs are equipotent inhibitors of prostaglandin and thromboxane generation.
Naunyn-Schmiedeberg's Archives of Pharmacology  •  2004  |  View Paper
Non-steroidal anti-inflammatory drugs inhibit prostaglandin synthetase and the ocular effects of arachidonic acid , its substrate.
Documenta Ophthalmologica  •  2004  |  View Paper
For example, … of the arachidonic acid cascade are considered to be mediators of the inflammatory response: they are formed during the process, contribute to the symptoms of …, vascular leakage, fever, pain and chemotaxis, and inhibition of their biosynthesis can be achieved at different levels by the anti-inflammatory drugs.
Inflammation  •  2004  |  View Paper
Show More